These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 32382328)
1. Overexpression of LBX2 associated with tumor progression and poor prognosis in colorectal cancer. Huang X; Yang Y; Yang C; Li H; Cheng H; Zheng Y Oncol Lett; 2020 Jun; 19(6):3751-3760. PubMed ID: 32382328 [TBL] [Abstract][Full Text] [Related]
2. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer. Li H; Dai S; Zhen T; Shi H; Zhang F; Yang Y; Kang L; Liang Y; Han A Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052 [TBL] [Abstract][Full Text] [Related]
3. LncRNA LBX2-AS1 promotes colorectal cancer progression and 5-fluorouracil resistance. Ma YN; Hong YG; Yu GY; Jiang SY; Zhao BL; Guo A; Wang Y; Cui XM; Hao LQ; Zheng H Cancer Cell Int; 2021 Sep; 21(1):501. PubMed ID: 34535128 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-519d-3p inhibits cell proliferation and migration by targeting TROAP in colorectal cancer. Ye X; Lv H Biomed Pharmacother; 2018 Sep; 105():879-886. PubMed ID: 30021381 [TBL] [Abstract][Full Text] [Related]
5. CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data. Zhang W; Xu TT; An ZT; Wei LF; Gu C; Li H; Tian YZ J Gastrointest Oncol; 2022 Apr; 13(2):657-671. PubMed ID: 35557589 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer. Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma. Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X Dig Dis Sci; 2019 Oct; 64(10):2878-2892. PubMed ID: 30949905 [TBL] [Abstract][Full Text] [Related]
8. Ring finger protein 215 is a potential prognostic biomarker involved in immune infiltration and angiogenesis in colorectal cancer. Wu JB; Li XJ; Liu H; Liu XP Biomed Rep; 2023 Jul; 19(1):50. PubMed ID: 37383678 [TBL] [Abstract][Full Text] [Related]
9. Quiescin Sulfhydryl Oxidase 2 Overexpression Predicts Poor Prognosis and Tumor Progression in Patients With Colorectal Cancer: A Study Based on Data Mining and Clinical Verification. Jiang T; Zheng L; Li X; Liu J; Song H; Xu Y; Dong C; Liu L; Wang H; Wang S; Wang R; Song J Front Cell Dev Biol; 2021; 9():678770. PubMed ID: 34858968 [No Abstract] [Full Text] [Related]
10. Screening and preliminary validation of miRNAs with the regulation of hTERT in colorectal cancer. Qin YZ; Xie XC; Liu HZ; Lai H; Qiu H; Ge LY Oncol Rep; 2015 Jun; 33(6):2728-36. PubMed ID: 25845814 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-1296 Facilitates Proliferation, Migration And Invasion Of Colorectal Cancer Cells By Targeting SFPQ. Tao Y; Ma C; Fan Q; Wang Y; Han T; Sun C J Cancer; 2018; 9(13):2317-2326. PubMed ID: 30026827 [TBL] [Abstract][Full Text] [Related]
12. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer. Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771 [No Abstract] [Full Text] [Related]
13. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study. Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286 [TBL] [Abstract][Full Text] [Related]
14. Abnormal expression of ABCD3 is an independent prognostic factor for colorectal cancer. Zhang Y; Zhang Y; Wang J; Yang J; Yang G Oncol Lett; 2020 May; 19(5):3567-3577. PubMed ID: 32269631 [TBL] [Abstract][Full Text] [Related]
15. Effect of ISM1 on the Immune Microenvironment and Epithelial-Mesenchymal Transition in Colorectal Cancer. Wu Y; Liang X; Ni J; Zhao R; Shao S; Lu S; Han W; Yu L Front Cell Dev Biol; 2021; 9():681240. PubMed ID: 34350177 [No Abstract] [Full Text] [Related]
16. MiR-378a-3p Acts as a Tumor Suppressor in Colorectal Cancer Stem-Like Cells and Affects the Expression of MALAT1 and NEAT1 lncRNAs. Castellani G; Buccarelli M; Lulli V; Ilari R; De Luca G; Pedini F; Boe A; Felli N; Biffoni M; Pilozzi E; Marziali G; Ricci-Vitiani L Front Oncol; 2022; 12():867886. PubMed ID: 35814429 [TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer. Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968 [TBL] [Abstract][Full Text] [Related]
18. miR-422a is an independent prognostic factor and functions as a potential tumor suppressor in colorectal cancer. Zheng GX; Qu AL; Yang YM; Zhang X; Zhang SC; Wang CX World J Gastroenterol; 2016 Jun; 22(24):5589-97. PubMed ID: 27350737 [TBL] [Abstract][Full Text] [Related]
19. Decreased E2F2 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Colorectal Cancer. Shang Y; Zhang Y; Liu J; Chen L; Yang X; Zhu Z; Li D; Deng Y; Zhou Z; Lu B; Fu CG J Cancer; 2022; 13(2):653-668. PubMed ID: 35069909 [TBL] [Abstract][Full Text] [Related]
20. Dysregulation of MALAT1 and miR-619-5p as a prognostic indicator in advanced colorectal carcinoma. Qiu G; Zhang XB; Zhang SQ; Liu PL; Wu W; Zhang JY; Dai SR Oncol Lett; 2016 Dec; 12(6):5036-5042. PubMed ID: 28101234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]